← Browse by Condition
Medical Condition
unresectable pancreatic ductal adenocarcinoma
Total Trials
3
Recruiting Now
3
Trial Phases
Phase 2, EARLY_Phase 1, Phase 1
NCT04887805 Phase 2
Recruiting
Lenvatinib and Pembrolizumab Maintenance Therapy for the Treatment of Patients of Advanced Unresectable Pancreatic Cancer
Enrollment
28 pts
Location
United States
Sponsor
City of Hope Medical Center
NCT04005690 EARLY_Phase 1
Recruiting
Targeted Pathway Inhibition in Patients With Pancreatic Cancer
Enrollment
90 pts
Location
United States
Sponsor
OHSU Knight Cancer Institute
NCT06454383 Phase 1
Recruiting
Gemcitabine and Leflunomide in Patients With Advanced Unresectable Pancreatic Cancer
Enrollment
19 pts
Location
United States
Sponsor
City of Hope Medical Center